Shopping Cart
- Remove All
- Your shopping cart is currently empty
N-Acetylgalactosamine-6-Sulfatase (GALNS) is a potential universal biomarker for several malignant tumors, including lung cancer, breast cancer, and head and neck cancer. Insufficient activity of N-Acetylgalactosamine-6-Sulfatase can lead to mucopolysaccharidosis type IVA (MPS IVA), also known as Morquio A syndrome. This enzyme is utilized in research related to MPS IVA and cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
20 μg | Inquiry | Inquiry | |
100 μg | Inquiry | Inquiry | |
1 mg | Inquiry | Inquiry |
Description | N-Acetylgalactosamine-6-Sulfatase (GALNS) is a potential universal biomarker for several malignant tumors, including lung cancer, breast cancer, and head and neck cancer. Insufficient activity of N-Acetylgalactosamine-6-Sulfatase can lead to mucopolysaccharidosis type IVA (MPS IVA), also known as Morquio A syndrome. This enzyme is utilized in research related to MPS IVA and cancer. |
Synonyms | N-Acetylgalactosamine-6-Sulfatase, GALNS, EC:3.1.6.4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.